Stay updated on GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Sign up to get notified when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.
Latest updates to the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check19 days agoChange DetectedThe website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedNo new additions were noted, but a significant section of content related to downloading data formats and selecting study fields has been removed.SummaryDifference14%
- Check40 days agoChange DetectedSeveral key government health and research websites have been removed from the monitored list.SummaryDifference0.7%
- Check48 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new links to health-related resources and providing detailed options for downloading study data in various formats.SummaryDifference17%
- Check55 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.3%
Stay in the know with updates to GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.